Matthew Zuga

Matthew Zuga

Direttore Finanziario/CFO presso ACUMEN PHARMACEUTICALS, INC.

Patrimonio netto: 327 405 $ in data 31/05/2026

60 anni
Finance
Health Technology
Consumer Services

Profilo

Matthew W.
Zuga
was the founder of Red Abbey Venture Partners LLC, founded in 2004, serving as Managing Director from 2011 to 2022.
Mr. Zuga was the founder of Red Abbey LLC, founded in 2004, serving as Member from 2004 to 2012.
Mr. Zuga is the founder of HighCape Partners Management LLC, founded in 2013, serving as Partner since 2013.
Current jobs include Co-Chairman at Alba Therapeutics Corp., Director at AgriMetis LLC, Director at MF Fire, Inc., Director at Reason To Believe LLC, Chief Financial & Business Officer at Acumen Pharmaceuticals, Inc. since 2021, Managing Member at HighCape Co Investment Vehicle I LLC, Managing Member at HighCape Co Investment Vehicle II LLC, and Partner at HighCape Capital LLC since 2013.
Former jobs include Director at Sirtris Pharmaceuticals, Inc., Director at Arginetix, Inc., Independent Director at TELA Bio, Inc. from 2019 to 2020, Managing Director at Syngenta Ventures Pte Ltd. from 2012 to 2013, Director at Population Genetics Technologies Ltd., Managing Director at Syngenta Ventures in 2013, Managing Director at Legg Mason & Co. LLC (New York) from 1999 to 2003, Director, Chief Operating & Financial Officer at HighCape Capital Acquisition Corp.
from 2020 to 2021, Chief Financial & Operating Officer, Director at HighCape Capital Acquisition Corp.
II from 2020 to 2021, Independent Director at Elutia, Inc. from 2015 to 2025, Industrial Engineer at General Motors Corp., Investment Banker at Raymond James & Associates, Inc., Investment Banker at Legg Mason Wood Walker, Inc. in 1993, Principal at IBM Corp., Principal at Southeast Banking Corp., Investment Advisor at NMGF Management LLC, Member at Air National Guard in 1991, Managing Member at HighCape Partners GP LLC, and General Partner at HighCape Partners GP LP.
Education includes an undergraduate degree from The Ohio State University conferred in 1988 and an MBA from Kenan-Flagler Business School conferred in 1993.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
08/04/2026 125.925 ( 0,17% ) 327 405 $ 31/05/2026
29/05/2025 0 ( -.--% ) - $ 31/05/2026

Posizioni attive di Matthew Zuga

SocietàPosizioneInizio
ACUMEN PHARMACEUTICALS, INC. Direttore Finanziario/CFO 01/05/2021
HighCape Co Investment Vehicle II LLC
Corporate Officer/Principal -
HighCape Co Investment Vehicle I LLC
Corporate Officer/Principal -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Direttore/Membro del Consiglio -
Fondatore 01/10/2013
Presidente -
Highcape Capital LLC
Corporate Officer/Principal 01/10/2013

Precedenti posizioni note di Matthew Zuga

SocietàPosizioneFine
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Matthew Zuga

Formazione di Matthew Zuga

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

90

Relazioni di 1° grado

32

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private32

Consumer Durables

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Syngenta Ventures Pte Ltd.

Health Technology

Finance

Electronic Technology

Finance

Consumer Services

Finance

Finance

Commercial Services

Red Abbey LLC

Government

Finance

Consumer Services

Miscellaneous

Finance

HighCape Partners GP LLC

HighCape Partners GP LP

Producer Manufacturing

Health Technology

Consumer Non-Durables

Finance

Highcape Capital LLC

HighCape Co Investment Vehicle I LLC

HighCape Co Investment Vehicle II LLC

Finance

  1. Mercati
  2. Insiders
  3. Matthew Zuga
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA